Abstract
Biorecognition, or molecular recognition, can be defined as the process in which biological molecules interact. This process is the basis of all biological interactions and therefore a key to sustain living systems. In spite of the paramount importance of these processes, the answers of many questions are still unresolved. For instance, how proteins can recognize other proteins, how receptors recognize specific ligands, or how antibodies recognize antigens has been the center of multiple studies and some of the molecular mechanisms of those interactions are not fully clear yet. The large amount of work developed in understanding biorecognition processes has been realized from different points of view. While several groups attempted to focus on protein–protein or protein–ligand interactions from a biophysical and structural perspective, others focused on complex interaction networks involved in signal transduction pathways, both in vivo and in vitro. Equally, protein–nucleic acid, protein–carbohydrate, protein–lipid, and even protein–solvent interactions have been investigated extensively. In spite of the multiple aspects that need further research, several aspects are currently understood and will be briefly described within this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilchek, M.; Bayer, E.A.; Livnah, O. Essentials of biorecognition: The (strept)avidin–biotin system as a model for protein–protein and protein–ligand interaction. Immunology Letters 2006, 103, 27–32.
Williams, D.H.; Stephens, E.; O’Brien, D.P.; Zhou, M. Understanding noncovalent interactions: Ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes. Angewandte Chemie-International Edition 2004, 43, 6596–6616.
Lee, L.K.; Ginsburg, M.A.; Crovace, C.; Donohoe, M.; Stock, D. Structure of the torque ring of the flagellar motor and the molecular basis for rotational switching. Nature 2010, 466, 996–1000.
Nierhaus, K.H.; Wilson, D. Protein synthesis and ribosome structure. Wiley: 2004.
Rodnina, M.V.; Wintermeyer, W.; Green, R. Ribosomes structure, function, and dynamics: Structure, function, and dynamics. Springer: 2011.
Blow, N. Systems biology: Untangling the protein web. Nature 2009, 460, 415–418.
Levy, M.; Ellington, A.D. Directed evolution of streptavidin variants using in vitro compartmentalization. Chemistry & Biology 2008, 15, 979–989.
Adams, J.; Nelson, B.; Sidhu, S. Recombinant genetic libraries and human monoclonal antibodies. In Human monoclonal antibodies, Steinitz, M., Ed. Humana Press: 2014; Vol. 1060, pp 149–170.
Grove, T.Z.; Cortajarena, A.L.; Regan, L. Ligand binding by repeat proteins: Natural and designed. Current Opinion in Structural Biology 2008, 18, 507–515.
Schreiber, G.; Fleishman, S.J. Computational design of protein–protein interactions. Current Opinion in Structural Biology 2013, 23, 903–910.
Grigoryan, G.; Reinke, A.W.; Keating, A.E. Design of protein-interaction specificity gives selective bzip-binding peptides. Nature 2009, 458, 859–864.
Schueler-Furman, O.; Wang, C.; Bradley, P.; Misura, K.; Baker, D. Progress in modeling of protein structures and interactions. Science 2005, 310, 638–642.
Zhao, M.; Wu, T.; Xiao, X.; Liu, Y.; Su, X. New advances in molecular recognition based on biomolecular scaffolds. Analytical and Bioanalytical Chemistry 2013, 405, 5679–5685.
Thomas, J.R.; Hergenrother, P.J. Targeting rna with small molecules. Chemical Reviews 2008, 108, 1171–1224.
Vendrell, M.; Zhai, D.; Er, J.C.; Chang, Y.-T. Combinatorial strategies in fluorescent probe development. Chemical Reviews 2012, 112, 4391–4420.
Bui, B.T.S.; Haupt, K. Molecularly imprinted polymers: Synthetic receptors in bioanalysis. Analytical and Bioanalytical Chemistry 2010, 398, 2481–2492.
Haupt, K. Biomaterials plastic antibodies. Nature Materials 2010, 9, 612–614.
Holliger, P.; Hudson, P.J. Engineered antibody fragments and the rise of single domains. Nature Biotechnology 2005, 23, 1126–1136.
Keefe, A.D.; Pai, S.; Ellington, A. Aptamers as therapeutics. Nature Reviews Drug Discovery 2010, 9, 537–550.
Reichert, J.M. Antibody-based therapeutics to watch in 2011. Mabs 2011, 3, 76–99.
Gervais, T.; Jensen, K.F. Mass transport and surface reactions in microfluidic systems. Chemical Engineering Science 2006, 61, 1102–1121.
Schuck, P.; Zhao, H. The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by spr biosensing. In Surface plasmon resonance, Mol, N.J.; Fischer, M.J.E., Eds. Humana Press: 2010; Vol. 627, pp 15–54.
Svitel, J.; Boukari, H.; Van Ryk, D.; Willson, R.C.; Schuck, P. Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation. Biophysical Journal 2007, 92, 1742–1758.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rodríguez-Hernández, J., Cortajarena, A. (2015). Selective Biorecognition on Polymer Surfaces: General Issues. In: Rodríguez-Hernández, J., Cortajarena, A. (eds) Design of Polymeric Platforms for Selective Biorecognition. Springer, Cham. https://doi.org/10.1007/978-3-319-17061-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-17061-9_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17060-2
Online ISBN: 978-3-319-17061-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)